Loading...
Market
Which company will be involved in the next major consumer health sector acquisition by June 2025?
2
Resolution / Starting Odds
Johnson & Johnson • 25%
Pfizer • 25%
GlaxoSmithKline • 25%
Other • 25%
Financial news outlets, company press releases
Story
Sanofi Nears €15.5 Billion Sale of 50% Stake in Opella to CD&R
Oct 11, 2024, 04:44 AM
Sanofi is nearing a significant deal to sell a 50% controlling stake in its consumer health unit, Opella, to Clayton Dubilier & Rice (CD&R). The transaction, valued at approximately €15.5 billion ($16 billion), is poised to be one of the largest deals of the year. CD&R has reportedly outbid rivals, including a consortium led by PAI Partners, to secure this acquisition. The sale, estimated at €15 billion, is seen as a critical health check for mega leveraged buyouts (LBOs) and underscores the growing interest in the consumer health sector.
View original story
Similar markets
Healthcare sector • 25%
Technology sector • 25%
Consumer goods sector • 25%
Other sector • 25%
Biotech company • 25%
Pharmaceutical company • 25%
Medical device company • 25%
Other • 25%
Amazon • 25%
Walmart • 25%
UnitedHealth Group • 25%
Other • 25%
Biotech company • 25%
Pharmaceutical company • 25%
Medical device company • 25%
Other • 25%
Venture Capital Firm • 25%
Private Equity Firm • 25%
Technology Company • 25%
Healthcare Company • 25%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Roche • 25%
Novartis • 25%
Pfizer • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Kaiser Permanente • 25%
Other • 25%
Biotech Company • 25%
Pharmaceutical Company • 25%
Medical Device Company • 25%
No major acquisition • 25%